BBLGW — Bone Biologics Corporation

BBLGWBone Biologics Corporation

NAS · US · Materials · Chemicals · bonebiologics.com

16.44USD+16.18%Mkt Cap: —P/E: —Last update: 2026-05-22

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromoti…

Industry Peers

Chemicals

PETKM

Petkim Petrokimya Holding Anonim Sirketi

Dottikon ES Holding AG

loading…

Indicators:|

Key Statistics

Company

Market Cap—

Enterprise Value—

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-3.11M USD

Revenue/Share—

Last Price16.44 USD

Fiscal Year End—

MR Quarter—

Employees2

CountryUS

SectorMaterials

IndustryChemicals

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B4.72

EPS (TTM)-0.14

EPS (Forward)—

52W Range

8.30029% of range35.95

52W High35.95 USD

52W Low8.300 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-57.81%

ROA-53.64%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-2.69M USD

CapEx (TTM)—

FCF Margin—

FCF Yield—

Net Debt-5.33M USD

Net Debt/EBITDA—

Balance Sheet

Debt/Equity—

Current Ratio13.85

Quick Ratio12.77

Book Value/Sh2.995 USD

Cash/Share2.971 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.—

Float1.79M

Insiders—

Institutions—

Technical

SMA 5019.66 (-16.4%)

SMA 20017.34 (-5.2%)

Beta0.53

S&P 52W Chg28.31%

Avg Vol (30d)130

Avg Vol (10d)60

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—